Background
==========

Prevalence of non-Hodgkin's lymphoma (NHL) subgroups throughout Africa, particularly among persons with HIV/AIDS, is unknown but increases in Burkitt lymphoma, plasmablastic lymphoma, and HHV-8 proliferation disorders have been noted. SSALC, an AIDS and Cancer Specimen Resource (ACSR/NCI) project, seeks to define indigenous sub-Saharan NHL subtypes using WHO classification (2008). Omoti (Univ. Benin 2007) defined an overall malignant lymphoma (ML) rate: 13.4/100,000 (1990s) including 17% Hodgkin's disease and 83% NHL but subgroups were not defined. Because regional HIV/AIDS prevalence is high, we subgrouped NHL and reviewed lymph node hyperplasia using stored material from Ahmadu Bello University Teaching Hospital in Zaria, Nigeria, to look for HIV/AIDS-associated lymphoid malignancies.

Materials and methods
=====================

Fifty-seven paraffin blocks were used to construct a tissue microarray (TMA), and whole tissue sections were H&E stained for morphology. TMA sections were stained using 30 monoclonal antibodies for common NHL antigens and Lana-1 for HHV-8 (immunohistochemical, IHC); in situ hybridization (ISH) for EBV-encoded RNA, kappa/lambda light chains (Ventana, Tucson, AZ), and fluorescent in situ hybridization (FISH) c-myc t(8;14) (Abbott/Vysis, Downer's Grove, IL).

Results
=======

There were 43 ML and 14 hyperplasic lymph nodes or reactive tissues. One lymph node was suspected for Castleman's disease but Lana-1 was negative. Table [1](#T1){ref-type="table"} lists ML subgroups.

###### 

Cases by diagnostic subgroup.

  ------------------------ -------------------- ---------------------------------------- ------------------ ---- ----
  **Subgroups**            **N**                **%NHL**                                                         
                                                                                                                 
                                                Burkitt lymphoma                                            19   51
                                                Lymphoblastic lymphoma: (pre-B)                             1    3
                                                Angioimmunoblastic T-cell lymphoma                          1    3
                                                Follicular lymphoma                                         6    16
                           **NHL**              Marginal zone lymphoma                                      1    3
  **ML**                                        Lymphoma not otherwise specified (NOS)                      2    5
                                                B-cell lymphoma, EBV+                                       1    3
                                                Diffuse large B-cell lymphoma            Activated B cell   4    11
                                                                                         NOS                1    3
                                                Malignant infiltrate (HHV-8 negative)                       1    3
                           Hodgkin\'s disease   5                                                                
  Reactive/normal tissue   15                                                                                    
  **Total**                **57**                                                                                
  ------------------------ -------------------- ---------------------------------------- ------------------ ---- ----

Conclusions
===========

Subgrouping ML with Hodgkin\'s disease (12%) and NHL (88%) is similar to the 2007 report from nearby Benin University. Burkitt lymphoma was the most common NHL at 51% followed by follicular lymphoma 16% and diffuse large B-cell lymphomas 14%. With the exception of Burkitt lymphoma, which is endemic in Nigeria, other NHL commonly associated with HIV/AIDS such as plasmablastic lymphoma and HHV-8 lymphoproliferative disorders were not identified.
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